Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL2404800 | 0.98 | NAAA (0.41) | NAAAL3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL22303945 | 0.92 | MGAM (0.43) | NAAAL3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL743529 | 0.88 | NAAA (0.53) | NAAAL3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL511413 | 0.88 | NAAA (0.53) | NAAAL3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL20446066 | 0.88 | NAAA (0.53) | NAAAL3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL511411 | 0.86 | NAAA (0.52) | NAAAL3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL702876 | 0.86 | NAAA (0.62) | NAAAL3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL1561849 | 0.85 | SMN1; SMN2 (0.44) | NAAADGKAALDH1A1HCAR2LMNA | |
| SCHEMBL1069145 | 0.84 | NAAA (0.66) | NAAAL3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL749593 | 0.84 | NAAA (0.66) | NAAAL3MBTL1MAPTMAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| US-20220106440-A1 | METHOD TO PREPARE BRANCHED POLYMERS OF LACTIC ACID | BIO VALORE WORLD S.P.A. SOCIETA' BENEFIT (IT) | 2022-04-07 | — | — | US | claimed |
| CN-113785001-A | Process for preparing branched polymers of lactic acid | 生物价值世界福利公司 | 2021-12-10 | — | — | CN | claimed |
| EP-3728394-A1 | METHOD TO PREPARE BRANCHED POLYMERS OF LACTIC ACID | Bio Valore World S.P.A. Societa' Benefit (IT) | 2020-10-28 | — | — | EP | claimed |
| US-20100172851-A1 | Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites | YU RUEY J | 2010-07-08 | — | — | US | claimed |
| WO-2006119283-A2 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J (US) | 2006-11-09 | — | — | WO | claimed |
| US-20060251597-A1 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J | 2006-11-09 | — | — | US | claimed |
| US-20260144734-A1 | NATURAL HAIR STYLING COMPOSITION AND METHOD FOR STYLING HAIR | L'OREAL (FR) | 2026-05-28 | — | — | US | disclosed |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | disclosed |
| EP-3395840-B1 | MODIFIED POLYOLEFIN RESIN | JUJO PAPER CO LTD (JP) | 2026-05-27 | — | — | EP | disclosed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| WO-2025132660-A1 | METHOD FOR TREATING HUMAN PERSPIRATION, AND ASSOCIATED COMPOSITION | L'OREAL (FR) | 2025-06-26 | — | — | WO | disclosed |
| CN-115516087-B | Novel polypeptide and method for producing L-leucine using the same | CJ第一制糖株式会社 | 2025-04-15 | — | — | CN | disclosed |
| EP-0831767-B1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 2004-09-22 | — | — | EP | disclosed |
| EP-0831767-A4 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-0831767-A1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | Yu, Ruey J., Dr. (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5686489-A | TOPICALLY APPLIED TO INDUCE GLYCOSAMINOGLYCAN, PROTEOGLYCAN, COLLAGEN AND ELASTIN BIOSYNTHESIS; WRINKLE RESISTANCE | TRISTRATA TECHNOLOGY, INC. (US) | 1997-11-11 | — | — | US | disclosed |
| WO-1996040047-A1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 1996-12-19 | — | — | WO | disclosed |
| US-4588583-A | ACRYLATES, ESTERS, BONE CEMENT | BEIERSDORF AKTIENGESELLSCHAFT (DE) | 1986-05-13 | — | — | US | disclosed |
| US-4005189-A | Process of suppressing odors employing deodorants containing esters of aliphatic hydroxycarboxylic acids | HENKEL & CIE G.M.B.H. (DT) | 1977-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | NAAA 757/4885L3MBTL1 2663/4885MAPT 486/4885 |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | NAAA 3538/4885L3MBTL1 1103/4885MAPT 2477/4885 |
| US-20260144734-A1 | NATURAL HAIR STYLING COMPOSITION AND METHOD FOR STYLING HAIR | SUCLG1, ALG3, DPM1 | NAAA 4479/4885L3MBTL1 3266/4885MAPT 2139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.